Solvay Pharma Россия и СНГ Обратная связь Карта сайта
Суббота, 27 декабря 2008 г.
Сделать стартовойДобавить в избранноеСообщить о странице другуW@PAvantGoPDA
В стремлении к прогрессу, с заботой о людях
XV Российский национальный конгресс "Человек и лекарство"


Включен в программу ОНЛС

  1. Berthelot J, Centonze M. Etude controlee en double aveugle Duspatalin (mebeverine) contre placebo, dans Ie traitement du colon irritable. Gaz Med Fr 1981; 88/16: 2341-2343
  2. Boisson J, Coudert Ph et al. Tolerance de la mebeverine a long terme. Act Ther 1987; 16: 289-292
  3. Cann PA. How to assess the effectiveness of a therapy in irritable bowel syndrome (IBS). In "Calcium Antagonism in Gastrointestinal Motility" Ed. Christen Т et al, Pub. Elsevier, 1989: 43-48
  4. Connell AM. Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon. Br MedJ 1965; 2: 848-851
  5. Daly J, Bergin A, Sun WM, Read NW. Effect of food and anti-cholinergic drugs on the pattern of rectosigmoid contractions. Gut 1993; 34: 799-802
  6. Delaunay P, Veron M. Colopathies fonctionnelles des sujets ages: efficacite et tolerance d'une nouvelle forme galenique. Gaz Med 1986; 93: 102-106
  7. Delvaux M, Ribet A. Etude de I'efficacite, de I'innocuite et de la tolerance de Duspatalin® 200mg gelules chez des patients presentant des troubles fonctionnels du tractus gastro-intestinal (colopathie fonctionelle). Abstract Gastro 1994; 84: 2-3
  8. Dickinson RG. Facile hydrolysis of mebeverine in vitro and in vivo: negligible circulation concentrations of the drug after oral administration. J Pharm Sci 1991; 80: 952-957
  9. Estrada A, de Azevedo V. Ensaio de um novo medicamento na dor abdominal recorrente, em pediatria. Med Policlin 1985; 146: 21-28
  10. Evans PR, Bak Y-T, Kellow JE. Mebeverine alters small bowel motility in irritable bowel syndrome. Aliment Pharmakol Ther 1996; 10: 787-793
  11. Fletcher СР. Clinical experience with mebeverine 200 mg. Data of File, Solvay 1997.
  12. Le Gal M, Peloux Ch. Colopathie fonctionnelle. Impact Medecin 1989; 3 Juin: 2-4
  13. Gilly R. Douleurs abdominales fonctionnelles de I'enfant. Med enfance 1989; March: 159-162
  14. Grillage MG, Nankani JN et al. A randomised, double-blind study of mebeverine versus dicyclomine in the treatment of functional abdominal pain in young adults. Br J Clin Pract 1990; 44: 176-179
  15. Guyot P, and a General Practitioner Group of the General Practitioners' Research Association. Efficacy of "Duspatalin" 200mg in patients with irritable bowel syndrom. Results of a descriptive study on various symptom subgroups. Act Med Int-Gastroenterologie 1997; 11: 2-7
  16. Den Hertog A, Van den Akker J. Modification of к,-receptor-operated channels by mebeverine in smooth muscle cells of guinea-pig taenia caeci. Eur J Pharmacol 1987; 138: 367-374
  17. Den Hertog A, Van den Akker J. The action of mebeverine and metabolites on mammalian non-myelinated nerve fibres. Eur J Pharmacol 1987; 139: 353-355
  18. Inauen W, Halter F. Clinical efficacy, safety and tolerance of mebeverine prolonged release (200mg) vs mebeverine tablets in patients with irritable bowel syndrome. Drug Invest 1994; 8 (4): 234-240
  19. Kastein E. Report on the safety and tolerance of mebeverine 810mg daily dose. Data on File, Solvay, 1988.
  20. Parks TG. Colonic motility in man. Postgrad MedJ 1973; 49: 90-99
  21. Poynard Т, Naveau S, Могу В, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 499-510
  22. Prout BJ. The treatment of irritable bowel syndrome: two doses of mebeverine compared. Lancet 1975; ii: 1260
  23. Salandre D, Mignon M. Efficacite comparee de la fenoverine et de la mebeverine chez 192 patients attients de troubles fonctionnels intestinaux. Gaz Med 1989; 96: 62-67
  24. SeccoGB, Di Somma С et al. Studio clinico controllato sulla azione del cloridrato di mebeverina nel trattamento del colon irritabile. Min Med 1983;p 74: 699-702
  25. Tasman-Jones С. Mebeverine in patients with the irritable colon syndrome: double blind study. N Z Med J 1973; 77: 232-235
  26. Tudor GJ. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome. Br J Clin Pract 1986; 40: 276-278
  27. Van Outryve M, Mayeur S, Meeus MA, Rosillon D, Hendrickx B, Ceuppens M. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. J Clin Pharm Ther 1995; 20: 277-28

Solvay Pharma Реклама: SOLVAY wap-сайт Солвей-Фарма
Баннерная сеть Солвей-Фарма.ру

Последнее обновление  27.12.2008 г.